Credit check at St. Jude
Jason Mills, an analyst for Canaccord Genuity, maintained his "sell" rating on St. Jude Medical, believing the stock is overvalued. But that doesn't mean he dislikes management.
"Let us give credit where credit is due," Mills wrote last week. "Management has built a successful large-cap company over the past decade."
According to Bloomberg, analysts covering St. Jude have 14 "buy" ratings, 11 "holds" and two "sells."
tough sledding at Arctic Cat
Arctic Cat reported lower-than-expected third quarter sales and earnings last week, and the stock got hammered.
A new partnership with Yamaha lowered profits, but analysts on the company's conference call said they've heard good things about Arctic Cat products. Robert W. Baird analyst Craig Kennison said on the conference call that "in dealer checks, we hear a lot of enthusiasm about your new products."
Raymond James analyst Joseph Hovorka showed less enthusiasm on Friday, downgrading Arctic Cat from a "strong buy" to a "market perform."
According to Bloomberg, analysts covering Arctic Cat have three "buys," four "holds" and one "sell" recommendation.
Patrick Kennedy
